Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 22;16(8):e67532.
doi: 10.7759/cureus.67532. eCollection 2024 Aug.

Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review

Affiliations
Review

Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review

Brynne E Tynes et al. Cureus. .

Abstract

Seborrheic dermatitis (SD) is a common inflammatory skin condition characterized by itchy, sensitive patches of greasy, flaky skin in areas rich in sebaceous glands, such as the scalp. Cases range from asymptomatic to debilitating, with effective treatment in severe cases proving crucial to patient quality of life. Ketoconazole shampoo is a topical antifungal that is a promising treatment option for individuals affected by this condition.Numerous trials display significant improvement in irritation and scaling of scalp seborrheic dermatitis (SSD) with ketoconazole shampoo treatment. Most studies also report optimally low relapse rates as well as little to no side effects, including rare skin irritation that resolves with cessation of the drug. Based on these findings, ketoconazole shampoo seems to be a safe and effective treatment for SSD.The present investigation reviews knowledge and research regarding ketoconazole shampoo as a treatment for SSD for physician consideration in the clinical setting.

Keywords: ketoconazole; ketoconazole shampoo; narrative review; seborrheic dermatitis; topical antifungal.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Similar articles

Cited by

References

    1. Tucker D, Masood S. StatPearls. Vol. 19. Treasure Island, FL: StatPearls Publishing; 2024. Seborrheic dermatitis. - PubMed
    1. Diagnosing Disorders of Facial Erythema. [ Jun; 2024 ]. 2023. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0733863523000... https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0733863523000... - PubMed
    1. Scalp seborrheic dermatitis: what we know so far. Leroy AK, Cortez de Almeida RF, Obadia DL, Frattini S, Melo DF. Skin Appendage Disord. 2023;9:160–164. - PMC - PubMed
    1. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Van Tyle JH. Pharmacotherapy. 1984;4:343–373. - PubMed
    1. Ketoconazole beyond antifungal activity: bioinformatics-based hypothesis on lipid metabolism in dandruff and seborrheic dermatitis. Goularte-Silva V, Paulino LC. Exp Dermatol. 2022;31:821–822. - PubMed

LinkOut - more resources